Charles River Laboratories International CRL
NYSE CRL
$296.78 +1.68 (+0.57%)
As of: Aug 27, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Net Income Growth (3y) (2012 - 2026)

Charles River Laboratories International (CRL) Net Income Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn 8.44%
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn -7.69%
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn 15.47%
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn 3.93%
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn -6.41%
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn 14.70%
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn 42.35%
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn 2.87%
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn 16.51%
10 Charles River Laboratories International 14.28 Bn 14.09 Bn 452.07 Mn -26.15%

Historic Data

Download Data
DateValue
Jun 27, 2026 -26.15%
Dec 27, 2025 -51.26%
Sep 27, 2025 -17.13%
Jun 28, 2025 -21.91%
Mar 29, 2025 -35.23%
Dec 28, 2024 -52.24%
Sep 28, 2024 -12.56%
Jun 29, 2024 1.59%
Mar 30, 2024 5.22%
Dec 30, 2023 9.43%
Sep 30, 2023 -4.98%
Jul 1, 2023 13.69%
Apr 1, 2023 26.93%
Dec 31, 2022 32.93%
Sep 24, 2022 9.89%
Jun 25, 2022 35.68%
Mar 26, 2022 19.58%
Dec 25, 2021 32.44%
Sep 25, 2021 19.97%
Jun 26, 2021 18.25%